V10 Diagnostic Ultrasound System; cV10 Diagnostic Ultrasound System; H10 Diagnostic Ultrasound System; XV10 Diagnostic Ultrasound System; XH10 Diagnostic Ultrasound System; V10 ONE Diagnostic Ultrasound System; cV10 ONE Diagnostic Ultrasound System; H10 ONE Diagnostic Ultrasound System; XV10 ONE Diagnostic Ultrasound System; XH10 ONE Diagnostic Ultrasound System; HERA Z10 Diagnostic Ultrasound System
Samsung Medison Co., Ltd. · Decision date Oct 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-08 for 510(k) K263150, filed by Samsung Medison Co., Ltd. of Hongcheon-Gun, Korea. The submission covers eleven named diagnostic ultrasound systems: V10, cV10, H10, XV10, XH10, V10 ONE, cV10 ONE, H10 ONE, XV10 ONE, XH10 ONE and HERA Z10. The listed classification is System, Imaging, Pulsed Doppler, Ultrasonic, under regulation 892.1550, with primary product code IYN and subsequent codes ITX, IYO and LLZ; the review panel and medical specialty are Radiology.
SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The record shows a Traditional 510(k) received 09/08/2026, reviewed by a third party, and not a combination product. No predetermined change control plan was authorized. The record does not identify which components or features changed relative to the predicate, the predicate device itself, or any indications for use, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263150
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Samsung Medison Co., Ltd.
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Applicant
- Samsung Medison Co., Ltd.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K263150 received
Application receipt date recorded by FDA.
K263150 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Samsung Medison Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hongcheon-Gun
Sources and methodology
- Original FDA record: K263150
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


